Status:

UNKNOWN

CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study

Lead Sponsor:

University of Calgary

Conditions:

Nephrotic Syndrome in Children

Nephrotic Syndrome, Minimal Change

Eligibility:

All Genders

1-17 years

Brief Summary

CHILDNEPH is a pan-Canadian project to observe clinical care for children with nephrotic syndrome. Previous studies have indicated that there is wide practice variation in how health care providers tr...

Detailed Description

CHILDNEPH is an ongoing prospective longitudinal study of children with incident and prevalent nephrotic syndrome. Children are recruited from 12 centres across Canada and followed for at least 30 mon...

Eligibility Criteria

Inclusion

  • Diagnosis with Nephrotic Sydrome at initial presentation, first or second relapse

Exclusion

  • unable to participate in English or French
  • Nephrotic Syndrome is secondary to other disease
  • Younger than one year old or older than 17 years

Key Trial Info

Start Date :

August 3 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2022

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT03786263

Start Date

August 3 2014

End Date

March 31 2022

Last Update

May 6 2019

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Alberta Children's Hospital

Calgary, Alberta, Canada, T3B 6A8

2

Stollery Children's Hospital, University of Alberta

Edmonton, Alberta, Canada, T6G 2B7

3

British Columbia Children's Hospital

Vancouver, British Columbia, Canada, V6H 3V4

4

Winnipeg Children's Hospital, University of Manitoba

Winnipeg, Manitoba, Canada, R3A 1S1